rs41286886
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_000770.3(CYP2C8):c.541G>A(p.Val181Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00681 in 1,613,260 control chromosomes in the GnomAD database, including 48 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_000770.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CYP2C8 | NM_000770.3 | c.541G>A | p.Val181Ile | missense_variant | 4/9 | ENST00000371270.6 | |
CYP2C8 | NM_001198853.1 | c.331G>A | p.Val111Ile | missense_variant | 4/9 | ||
CYP2C8 | NM_001198855.1 | c.331G>A | p.Val111Ile | missense_variant | 5/10 | ||
CYP2C8 | NM_001198854.1 | c.235G>A | p.Val79Ile | missense_variant | 3/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CYP2C8 | ENST00000371270.6 | c.541G>A | p.Val181Ile | missense_variant | 4/9 | 1 | NM_000770.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00498 AC: 757AN: 151862Hom.: 4 Cov.: 32
GnomAD3 exomes AF: 0.00485 AC: 1220AN: 251290Hom.: 7 AF XY: 0.00477 AC XY: 648AN XY: 135808
GnomAD4 exome AF: 0.00701 AC: 10237AN: 1461280Hom.: 44 Cov.: 31 AF XY: 0.00682 AC XY: 4958AN XY: 726946
GnomAD4 genome AF: 0.00498 AC: 757AN: 151980Hom.: 4 Cov.: 32 AF XY: 0.00452 AC XY: 336AN XY: 74264
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 06, 2018 | - - |
CYP2C8-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 10, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at